SNY : NYSE : Health Care
$39.75 -0.46 | -1.1%
Today's Range: 39.42 - 39.88
Avg. Daily Volume: 2204200.0
01/24/17 - 1:46 PM ET

Financial Analysis

SANOFI's gross profit margin for the third quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income during the past quarter when compared with the same quarter a year ago, however, it was unable to keep up with the growth of the average competitor within its industry.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q3 FY16 Q3 FY15
Net Sales ($mil)10780.1810127.47
EBITDA ($mil)0.00.0
EBIT ($mil)3012.762527.78
Net Income ($mil)1927.491819.03

Balance Sheet Q3 FY16 Q3 FY15
Cash & Equiv. ($mil)0.00.0
Total Assets ($mil)0.00.0
Total Debt ($mil)0.00.0
Equity ($mil)0.00.0

Profitability Q3 FY16 Q3 FY15
Gross Profit Margin65.7464.24
EBITDA Margin0.00.0
Operating Margin27.9524.96
Sales Turnover0.00.0
Return on Assets0.00.0
Return on Equity0.00.0
Debt Q3 FY16 Q3 FY15
Current Ratio0.00.0
Interest Expense298.28139.74
Interest Coverage10.118.09

Share Data Q3 FY16 Q3 FY15
Shares outstanding (mil)2574.012612.25
Div / share0.00.0
Book value / share0.00.0
Institutional Own % n/a n/a
Avg Daily Volume2221086.02300253.0


HOLD. This stock's P/E ratio indicates a discount compared to an average of 26.64 for the Pharmaceuticals industry and a discount compared to the S&P 500 average of 25.41. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, SANOFI proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
SNY 22.95 Peers 26.64   SNY NA Peers 18.70

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

SNY is trading at a discount to its peers.


Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
SNY 13.66 Peers 14.20   SNY 0.33 Peers 0.50

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

SNY is trading at a valuation on par with its peers.


Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

SNY trades at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
SNY NA Peers 65.44   SNY -20.10 Peers -14.41

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

Ratio not available.


Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, SNY is expected to significantly trail its peers on the basis of its earnings growth rate.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
SNY 2.76 Peers 12.05   SNY -3.54 Peers 5.01

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

SNY is trading at a significant discount to its industry on this measurement.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

SNY significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades